208 related articles for article (PubMed ID: 32120037)
1. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
[TBL] [Abstract][Full Text] [Related]
2. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
[TBL] [Abstract][Full Text] [Related]
4. Lymphadenopathy Associated With Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable From Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study.
Yuan CT; Wang JT; Sheng WH; Cheng PY; Kao CJ; Wang JY; Chen CY; Liau JY; Tsai JH; Lin YJ; Chen CC; Chen YC; Chang SC; Wu UI
Am J Surg Pathol; 2021 Aug; 45(8):1138-1150. PubMed ID: 34010155
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.
Roerden M; Döffinger R; Barcenas-Morales G; Forchhammer S; Döbele S; Berg CP
BMC Infect Dis; 2020 Nov; 20(1):828. PubMed ID: 33176707
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
[TBL] [Abstract][Full Text] [Related]
7. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
[TBL] [Abstract][Full Text] [Related]
8. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
[TBL] [Abstract][Full Text] [Related]
9. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
[TBL] [Abstract][Full Text] [Related]
10. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
[TBL] [Abstract][Full Text] [Related]
11. Anti-interferon-γ Antibody-seropositive Disseminated Nontuberculous Mycobacterial Infection Mimicking POEMS and TAFRO Syndromes.
Hidekawa C; Yoshimi R; Kishimoto D; Kato H; Mitsuhashi M; Sakurai N; Sato Y; Uehara T; Iizuka Y; Komiya T; Hamada N; Nagai H; Soejima Y; Kamiyama R; Takase-Minegishi K; Kirino Y; Sakagami T; Nakajima H
Intern Med; 2022 Aug; 61(15):2377-2385. PubMed ID: 35022342
[TBL] [Abstract][Full Text] [Related]
12. Multiple refractory intracellular pathogen infections in a human immunodeficiency virus-negative patient with anti-interferon-γ autoantibodies: a case report.
Wang H; Lei R; Ji Y; Xu W; Zhang K; Guo X
BMC Infect Dis; 2023 Jul; 23(1):493. PubMed ID: 37495965
[TBL] [Abstract][Full Text] [Related]
13. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset immunodeficiency in Thailand and Taiwan.
Browne SK; Burbelo PD; Chetchotisakd P; Suputtamongkol Y; Kiertiburanakul S; Shaw PA; Kirk JL; Jutivorakool K; Zaman R; Ding L; Hsu AP; Patel SY; Olivier KN; Lulitanond V; Mootsikapun P; Anunnatsiri S; Angkasekwinai N; Sathapatayavongs B; Hsueh PR; Shieh CC; Brown MR; Thongnoppakhun W; Claypool R; Sampaio EP; Thepthai C; Waywa D; Dacombe C; Reizes Y; Zelazny AM; Saleeb P; Rosen LB; Mo A; Iadarola M; Holland SM
N Engl J Med; 2012 Aug; 367(8):725-34. PubMed ID: 22913682
[TBL] [Abstract][Full Text] [Related]
15. Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection.
Chi CY; Chu CC; Liu JP; Lin CH; Ho MW; Lo WJ; Lin PC; Chen HJ; Chou CH; Feng JY; Fung CP; Sher YP; Li CY; Wang JH; Ku CL
Blood; 2013 Feb; 121(8):1357-66. PubMed ID: 23243276
[TBL] [Abstract][Full Text] [Related]
16. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
[TBL] [Abstract][Full Text] [Related]
17. Disseminated nontuberculous mycobacterial infection in a patient with idiopathic CD4 lymphocytopenia and IFN-γ neutralizing antibodies: a case report.
Goto R; Shiota S; Kaimori R; Horinouchi N; Utsunomiya Nishimizu R; Yamamoto K; Miyazaki E
BMC Infect Dis; 2023 Jan; 23(1):58. PubMed ID: 36717786
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
[TBL] [Abstract][Full Text] [Related]
19. Disseminated nontuberculous mycobacterial infection with cryptic immunodeficiency mimicking malignancy: a case report.
Sun X; Zhang T; Sun H; Sun X
BMC Pulm Med; 2022 Nov; 22(1):452. PubMed ID: 36447235
[TBL] [Abstract][Full Text] [Related]
20. Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies.
Xie YL; Rosen LB; Sereti I; Barber DL; Chen RY; Hsu DC; Qasba SS; Zerbe CS; Holland SM; Browne SK
Clin Infect Dis; 2016 Mar; 62(6):770-773. PubMed ID: 26646678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
